Cyclometalated Ir(<scp>iii</scp>) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy

Abstract

The successful design and anticancer mechanistic studies of a series of cyclometalated Ir(III) complexes with histone deacetylase inhibitory and photodynamic therapy (PDT) activities are reported.